UA110921C2 - Пептид - Google Patents
ПептидInfo
- Publication number
- UA110921C2 UA110921C2 UAA201114970A UAA201114970A UA110921C2 UA 110921 C2 UA110921 C2 UA 110921C2 UA A201114970 A UAA201114970 A UA A201114970A UA A201114970 A UAA201114970 A UA A201114970A UA 110921 C2 UA110921 C2 UA 110921C2
- Authority
- UA
- Ukraine
- Prior art keywords
- peptide
- relates
- hemophilia
- antibody
- inhibitor
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 1
- 208000031220 Hemophilia Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 208000013633 acquired hemophilia Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0908515.0A GB0908515D0 (en) | 2009-05-18 | 2009-05-18 | Peptide |
| PCT/GB2010/000997 WO2010133834A2 (en) | 2009-05-18 | 2010-05-17 | Peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA110921C2 true UA110921C2 (uk) | 2016-03-10 |
Family
ID=40834163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201114970A UA110921C2 (uk) | 2009-05-18 | 2010-05-17 | Пептид |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8703705B2 (https=) |
| EP (2) | EP2432494A2 (https=) |
| JP (1) | JP5784009B2 (https=) |
| KR (1) | KR101673889B1 (https=) |
| CN (1) | CN102458445B (https=) |
| AU (1) | AU2010250957B2 (https=) |
| BR (1) | BRPI1012845A2 (https=) |
| CA (1) | CA2762020C (https=) |
| CL (1) | CL2011002893A1 (https=) |
| CO (1) | CO6460780A2 (https=) |
| CY (1) | CY1115832T1 (https=) |
| DK (1) | DK2465523T3 (https=) |
| EA (1) | EA027229B1 (https=) |
| EC (1) | ECSP11011540A (https=) |
| ES (1) | ES2525448T3 (https=) |
| GB (1) | GB0908515D0 (https=) |
| HR (1) | HRP20141182T1 (https=) |
| IL (1) | IL216199A (https=) |
| MX (1) | MX2011012270A (https=) |
| MY (1) | MY168207A (https=) |
| NZ (2) | NZ613713A (https=) |
| PL (1) | PL2465523T3 (https=) |
| PT (1) | PT2465523E (https=) |
| RS (1) | RS53671B1 (https=) |
| SG (2) | SG190573A1 (https=) |
| SI (1) | SI2465523T1 (https=) |
| SM (1) | SMT201400186B (https=) |
| UA (1) | UA110921C2 (https=) |
| WO (1) | WO2010133834A2 (https=) |
| ZA (1) | ZA201108446B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2506868T1 (en) | 2009-12-06 | 2018-04-30 | Bioverativ Therapeutics Inc. | HYPER AND HYBRID POLYPETTIDES FACTOR VIII-FC AND METHODS FOR THEIR USE |
| EA036483B1 (ru) * | 2012-11-12 | 2020-11-16 | Эпитоп Интернэшнл Нв | Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии |
| GB201314052D0 (en) * | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| PE20231949A1 (es) | 2015-10-30 | 2023-12-05 | Spark Therapeutics Inc | VARIANTES DEL FACTOR VIII REDUCIDO CON CpG, COMPOSICIONES Y METODOS Y USOS PARA EL TRATAMIENTO DE TRASTORNOS DE LA HEMOSTASIA |
| MX2019006444A (es) | 2016-12-02 | 2019-10-30 | Bioverativ Therapeutics Inc | Métodos de tratamiento de artropatía hemofílica utilizando factores de coagulación quiméricos. |
| PL3793588T3 (pl) | 2018-05-18 | 2025-09-01 | Bioverativ Therapeutics Inc. | Sposoby leczenia hemofilii a |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764425B (zh) | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
| AU2002249779A1 (en) * | 2000-12-01 | 2002-08-12 | Regents Of The University Of Minnesota | Method to treat hemophilia |
| WO2002096454A1 (en) | 2001-05-31 | 2002-12-05 | D. Collen Research Foundation Vzw | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| WO2002098454A2 (en) | 2001-05-31 | 2002-12-12 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| WO2003087161A1 (en) | 2002-04-18 | 2003-10-23 | Merck Patent Gmbh | Modified factor viii |
| GB0723712D0 (en) * | 2007-12-04 | 2008-01-16 | Apitope Technology Bristol Ltd | Peptides |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
-
2009
- 2009-05-18 GB GBGB0908515.0A patent/GB0908515D0/en not_active Ceased
-
2010
- 2010-05-17 DK DK12159740.5T patent/DK2465523T3/en active
- 2010-05-17 MX MX2011012270A patent/MX2011012270A/es active IP Right Grant
- 2010-05-17 NZ NZ613713A patent/NZ613713A/en not_active IP Right Cessation
- 2010-05-17 RS RS20140660A patent/RS53671B1/sr unknown
- 2010-05-17 EA EA201171430A patent/EA027229B1/ru not_active IP Right Cessation
- 2010-05-17 US US13/320,201 patent/US8703705B2/en not_active Expired - Fee Related
- 2010-05-17 CA CA2762020A patent/CA2762020C/en not_active Expired - Fee Related
- 2010-05-17 WO PCT/GB2010/000997 patent/WO2010133834A2/en not_active Ceased
- 2010-05-17 SI SI201030819T patent/SI2465523T1/sl unknown
- 2010-05-17 UA UAA201114970A patent/UA110921C2/uk unknown
- 2010-05-17 KR KR1020117028276A patent/KR101673889B1/ko not_active Expired - Fee Related
- 2010-05-17 BR BRPI1012845A patent/BRPI1012845A2/pt not_active IP Right Cessation
- 2010-05-17 NZ NZ596300A patent/NZ596300A/xx not_active IP Right Cessation
- 2010-05-17 CN CN201080032337.0A patent/CN102458445B/zh not_active Expired - Fee Related
- 2010-05-17 JP JP2012511336A patent/JP5784009B2/ja not_active Expired - Fee Related
- 2010-05-17 SG SG2013030713A patent/SG190573A1/en unknown
- 2010-05-17 SG SG2011084985A patent/SG176138A1/en unknown
- 2010-05-17 MY MYPI2011005515A patent/MY168207A/en unknown
- 2010-05-17 ES ES12159740.5T patent/ES2525448T3/es active Active
- 2010-05-17 PT PT121597405T patent/PT2465523E/pt unknown
- 2010-05-17 EP EP10721533A patent/EP2432494A2/en not_active Withdrawn
- 2010-05-17 EP EP12159740.5A patent/EP2465523B1/en active Active
- 2010-05-17 PL PL12159740T patent/PL2465523T3/pl unknown
- 2010-05-17 AU AU2010250957A patent/AU2010250957B2/en not_active Ceased
-
2011
- 2011-11-07 IL IL216199A patent/IL216199A/en not_active IP Right Cessation
- 2011-11-17 CL CL2011002893A patent/CL2011002893A1/es unknown
- 2011-11-17 CO CO11156774A patent/CO6460780A2/es active IP Right Grant
- 2011-11-17 ZA ZA2011/08446A patent/ZA201108446B/en unknown
- 2011-12-16 EC EC2011011540A patent/ECSP11011540A/es unknown
-
2014
- 2014-12-06 HR HRP20141182AT patent/HRP20141182T1/hr unknown
- 2014-12-15 SM SM201400186T patent/SMT201400186B/xx unknown
- 2014-12-17 CY CY20141101057T patent/CY1115832T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201070271A1 (ru) | Пептиды для получения вакцины | |
| JOP20180103B1 (ar) | التركيب الصيدلاني للكاربيتوسين | |
| MX382899B (es) | Composiciones y métodos que comprenden variantes de proteasa termolisina. | |
| MA34521B1 (fr) | Polypeptides de relaxine modifiés et leurs utilisations | |
| EP2569330A4 (en) | CHLOROTOXIN VARIANTS AND CONJUGATES AND METHOD OF USE THEREOF | |
| DE602008002693D1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
| UA118167C2 (uk) | Пептид та його застосування | |
| EA201290772A1 (ru) | Новые формы ивабрадина гидрохлорида | |
| JOP20200039A1 (ar) | مُستحضر صيدلي يشتمل على hcg مأشوب | |
| MX336737B (es) | Composiciones y metodos que comprenden variantes de proteasa serina. | |
| BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
| ES2691070T3 (es) | Péptidos antiinflamatorios y composición que comprende los mismos | |
| ECSP12011990A (es) | Isoquinolinonas y quinazolinonas sustituidas | |
| UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид | |
| PH12013500065A1 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
| PH12013500899A1 (en) | Modified factor ix polypeptides and uses thereof | |
| ATE516853T1 (de) | Zyklische peptid-cxcr4-antagonisten | |
| MA37506A1 (fr) | Utilisations thérapeutiques de protéines de facteur de croissance des fibroblastes 21 | |
| MX2012001346A (es) | Polipeptidos del factor ix modificados y usos de los mismos. | |
| UA110921C2 (uk) | Пептид | |
| MX2011008179A (es) | Peptidos para vacuna. | |
| EA201290792A1 (ru) | Пептиды для вакцины против аллергии на березу | |
| MX2010010457A (es) | Vectores recombinantes de rinovirus. | |
| GB201118201D0 (en) | Novel peptides | |
| MA32321B1 (fr) | Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers |